Corporate News     17-Sep-19
SMS Lifesciences India update on USFDA's recent statement on Ranitidine API products
SMS Lifesciences India announced that the company has been manufacturing Ranitidine HCL (API) since 1990 and currently selling it to various markets except for USA (USDMF grade) and EU (CEP grade). Recently, USFDA and EMA have become aware of the presence of NDMA (N-Nitrosodimethylamine), a carcinogenic impurity, at low levels in some Ranitidine API products. USFDA in a statement on 13 September, informed that they are evaluating the presence of this impurity and the impact (if any) of this impurity on patients.

Since, the company is one of the major manufacturers of Ranitidine API in the world, the company is evaluating its own Ranitidine product and its processes to ensure that its API is void of this NDMA impurity or are within permissible limits.

Previous News
  SMS Lifesciences India consolidated net profit rises 71.24% in the December 2022 quarter
 ( Results - Announcements 10-Feb-23   16:53 )
  SMS Lifesciences India consolidated net profit declines 17.08% in the June 2022 quarter
 ( Results - Announcements 10-Aug-22   08:12 )
  SMS Lifesciences India reports consolidated net profit of Rs 2.70 crore in the December 2020 quarter
 ( Results - Announcements 13-Feb-21   10:52 )
  Board of SMS LifeSciences India recommends final dividend
 ( Corporate News - 30-May-23   16:12 )
  SMS LifeSciences India to hold AGM
 ( Corporate News - 03-Sep-21   14:16 )
  SMS LifeSciences India to announce Quarterly Result
 ( Corporate News - 12-Nov-21   14:16 )
  SMS Lifesciences soars after API Facility completes USFDA Inspection with No Observations
 ( Hot Pursuit - 11-Apr-22   11:29 )
  SMS LifeSciences India to convene board meeting
 ( Corporate News - 28-Aug-21   16:16 )
  SMS Lifesciences India consolidated net profit rises 209.67% in the September 2021 quarter
 ( Results - Announcements 14-Nov-21   16:27 )
  SMS Lifesciences India reports consolidated net loss of Rs 1.80 crore in the June 2023 quarter
 ( Results - Announcements 09-Aug-23   07:41 )
  SMS LifeSciences India announces board meeting date
 ( Corporate News - 08-Nov-22   12:40 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top